The effects of bradykinin and sequence-related analogs on the response properties of cutaneous nociceptors in monkeys

Somatosensory & Motor Research

Volumn 9, Issue 2, 1992, Pages 97-106

  Khan, Adil A ^a   Raja, Srinivasa N ^a   Manning, Donald C ^a   Campbell, James N ^a   Meyer, Richard A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Bradykinin; Bradykinin analogs; Hyperalgesia; Inflammation; Nociceptors; Pain; Primary afferents; Sensitization

Indexed keywords

BRADYKININ; BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EVOKED RESPONSE; HEAT SENSITIVITY; HYPERALGESIA; MONKEY; MUSCLE SPINDLE AFFERENT NERVE; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; RECEPTIVE FIELD; SKIN NERVE; SKIN RECEPTOR;

AFFERENT PATHWAYS; ANALGESICS; ANIMAL; BRADYKININ; EVOKED POTENTIALS, SOMATOSENSORY; MACACA FASCICULARIS; NERVE FIBERS; NERVE FIBERS, MYELINATED; NOCICEPTORS; SENSORY THRESHOLDS; SKIN; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPTIC TRANSMISSION;

EID: 0026788372     PISSN: 08990220     EISSN: None     Source Type: Journal    
DOI: 10.3109/08990229209144765     Document Type: Article

References (57)

1. Development of pain-producing substance in human plasma
2. Bradykinin stimulates phospholipid methylation, calcium influx, prostaglandin formation, and cAMP accumulation in human fibroblasts
3. Bradykinin and serotonin effects on various types of cutaneous nerve fibers
4. Response of cutaneous sensory units with unmyelinated fibers to noxious stimuli
5. Bradykinin receptor antagonists
6. Sensitization of unmyelinated nociceptive afferents in the monkey varies with skin type
7. Plasticity of the neural events related to pain
8. Sensitization of myelinated nociceptive afferents that innervate monkey hand
9. Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts
10. Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist
11. Chemosensitivity and sensitization of mechanically insensitive afferents in the primate
12. The pharmacology of bra-dykinin receptors
13. Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33–824, beta-endorphin and morphine
14. Continuous skin perfusion in vivo as a method for study of pharmacological agents in human skin
15. Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venocon-striction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit
16. Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat
17. Influences of algogenic substances and prostaglandins on the discharges of unmyelinated cutaneous nerve fibers identified as nociceptors
18. What peripheral mechanisms contribute to nociceptive transmission and hyperalgesia?
19. Bradykinin is increased during acute and chronic inflammation: Therapeutic implications
20. Bradykinin-activated transmembrane signals are coupled via No or Ni to production of inositol 1,4,5-triphosphate, a second messenger in NG108–15 neuroblastoma-glioma hybrid cells
21. The chemistry of pain production
22. Thermally potentiated responses to algesic substances of visceral nociceptors
23. Modulation of testicular polymodal receptor activities
24. Primate cutaneous sensory units with unmyelinated (C) afferent fibers
25. Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat
26. Chemosensitivity of fine afferents from rat skin in vitro
27. New, long-acting, potent bradykinin antagonists
28. Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic efFect
29. Manifestation of pain in analgesic evaluation in animals and man
30. Identification of pre- and post-synaptic bradykinin receptor sites in the vas deferens: Evidence for differential structural prerequisites
31. Pain and hyperalgesia following intradermal injection of bradykinin in humans
32. Kinin receptors in experimental inflammation
33. Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs
34. Bradykinin enhances excitability in cultured rat sensory neurones by a GTP-dependent mechanism
35. Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2
36. Myelinated nociceptive afferents account for the hyperalgesia that follows a bum to the hand
37. Peripheral neural coding of pain sensation
38. Evidence for cutaneous afferents that are insensitive to mechanical stimuli
39. A laser stimulator for the study of cutaneous thermal pain sensation
40. The effects of bradykinin agonists and antagonists on visceral polymodal receptor activities
41. Modulation of immunity and hypersensitivity by sensory neuropeptides
42. Two different G-proteins mediate neuropeptide Y and bradykinin-stimulated phospholipid breakdown in cultured rat sensory neurons
43. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin
44. Peripheral mechanisms of somatic pain
45. Pharmacology of bradykinin and related kinins
46. De novo formation of vascular receptors for bradykinin
47. New synthetic antagonists of bradykinin
48. Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons
49. Bradykinin receptor-mediated cyclic GMP formation in a nerve cell population (murine neuroblastoma clone N1E-115)
50. Bradykinin as a pain mediator: Receptors are localized to sensory neurons and antagonists have analgesic actions
51. Bradykinin antagonists in pain and inflammation
52. Antagonists of B2 bradykinin receptors
53. Kinin antagonists: Design and activities
54. Selective responsiveness of polymodal nociceptors of the rabbit ear to capsaicin, bradykinin and ultra-violet irradiation
55. Competitive antagonists of bradykinin
56. The effect of kinin agonists and antagonists on the pain response of the human blister base
57. Endothelium from diverse vascular sources synthesizes platelet-activating factor